Catalent, Inc.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Techno…
Drug Manufacturers - Specialty & Generic
US, Somerset [HQ]
Ratios
14 Sheets · Starting from NoneMargins, Growth Rates In %
| Ratio | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | None | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||
| Gross Margin | 32.78 | 32.96 | 31.58 | 32.75 | 33.61 | 31.79 | 31.54 | 30.55 | 31.97 | 31.78 | 33.82 | 33.97 | 24.79 | - - | |
| Profit Margin | -3.53 | -1.44 | -2.59 | 0.89 | 11.59 | 6.03 | 5.29 | 3.39 | 5.46 | 5.59 | 14.63 | 10.34 | -5.43 | - - | |
| Operating Margin | 12.15 | 11.68 | 11.35 | 13.18 | 14.20 | 11.79 | 11.28 | 11.01 | 2.45 | 4.65 | 8.85 | 7.23 | -3.20 | - - | |
|
EPS Growth
|
- - | 54.35 | -90.48 | 135.00 | 1,164.29 | -49.72 | -1.12 | -27.27 | 43.75 | 25.00 | 173.91 | -13.02 | -146.72 | - - | |
| EPS USD | -46.00 | -21.00 | -40.00 | 14.00 | 177.00 | 89.00 | 88.00 | 64.00 | 92.00 | 115.00 | 315.00 | 274.00 | -128.00 | - - | |
| Return on Assets (ROA) | - - | -0.78 | -1.53 | 0.52 | 6.75 | 3.61 | 3.18 | 1.85 | 2.22 | 2.22 | 6.42 | 4.75 | -2.15 | - - | |
| Return on Equity (ROE) | - - | 6.96 | 11.37 | -4.36 | 33.47 | 17.53 | 15.18 | 7.69 | 8.17 | 5.97 | 14.94 | 10.41 | -5.01 | - - | |
| Return on Invested Capital (ROIC) | - - | 8.26 | 18.00 | 2.74 | 19.26 | 6.70 | 6.77 | 3.92 | 1.14 | 2.06 | 4.05 | 3.33 | -1.06 | - - | |
| Solvency | |||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | 85.49 | 88.05 | 87.72 | 60.02 | 60.19 | 60.21 | 60.06 | 47.85 | 38.81 | 35.57 | 39.99 | 44.97 | - - | |
| Debt/Equity | - - | -765.18 | -655.37 | -729.05 | 297.78 | 292.58 | 287.45 | 250.42 | 175.98 | 104.11 | 82.78 | 87.63 | 104.62 | - - | |
| Debt/EBITDA | - - | 721.23 | 728.02 | 1,040.33 | 737.10 | 705.39 | 735.69 | 818.67 | 900.10 | 519.45 | 364.70 | 516.23 | 5,783.54 | - - | |
|
Debt/Capitalization
|
- - | 115.03 | 118.01 | 115.90 | 74.86 | 74.53 | 74.19 | 71.46 | 63.77 | 51.01 | 45.29 | 46.70 | 51.13 | - - | |
| Long-Term Debt/Capitalization | - - | 115.32 | 118.29 | 116.07 | 74.62 | 74.24 | 73.96 | 70.91 | 63.16 | 50.40 | 44.71 | 46.52 | 48.20 | - - | |
| Interest Debt per Share USD | - - | 24.43 | 24.67 | 24.50 | 16.62 | 15.62 | 17.36 | 21.59 | 21.28 | 20.99 | 19.95 | 24.57 | 27.81 | - - | |
| Debt Growth | - - | - - | 0.30 | 0.71 | -30.35 | -1.45 | 11.78 | 30.85 | 8.75 | 1.98 | 7.39 | 29.65 | 15.40 | - - | |
| Liquidity | |||||||||||||||
| Current Ratio | - - | 160.41 | 165.22 | 151.77 | 184.84 | 201.99 | 225.97 | 214.99 | 208.11 | 256.72 | 243.98 | 272.01 | 177.77 | - - | |
| Quick Ratio | - - | 108.65 | 113.19 | 105.54 | 131.25 | 139.67 | 169.66 | 167.45 | 158.31 | 200.55 | 165.47 | 148.23 | 83.41 | - - | |
| Cash Ratio | - - | 31.64 | 25.93 | 16.42 | 37.92 | 33.64 | 61.47 | 71.10 | 51.50 | 106.72 | 74.92 | 41.88 | 18.58 | - - | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | |||||||||||||||
| Inventory Turnover | - - | 871.32 | 901.02 | 911.80 | 914.60 | 814.28 | 768.42 | 818.17 | 665.98 | 651.95 | 469.98 | 454.13 | 420.94 | - - | |
| Receivables Turnover | - - | 500.98 | 502.88 | 452.74 | 491.62 | 445.54 | 424.59 | 443.22 | 351.48 | 369.20 | 395.06 | 459.37 | 437.67 | - - | |
| Payables Turnover | - - | 846.65 | 816.78 | 829.91 | 948.13 | 877.18 | 870.59 | 890.58 | 669.63 | 657.63 | 687.27 | 757.25 | 753.16 | - - | |
|
Asset Turnover
|
- - | 53.99 | 58.89 | 59.15 | 58.21 | 59.79 | 60.08 | 54.37 | 40.72 | 39.79 | 43.88 | 45.95 | 39.66 | - - | |
| Fixed Turnover | - - | 209.31 | 221.03 | 209.36 | 206.82 | 204.03 | 208.39 | 193.88 | 163.86 | 162.79 | 158.40 | 154.40 | 115.60 | - - | |
| Coverage | |||||||||||||||
| Interest Coverage | 112.45 | 108.08 | 100.59 | 147.70 | 247.52 | 246.10 | 259.93 | 243.36 | 55.73 | 114.04 | 321.82 | 283.74 | -74.46 | - - | |
| Asset Coverage | - - | - - | - - | - - | 100 | 100 | 100 | 100 | 100 | 200 | 200 | 200 | 100 | - - | |
| Cash Flow Coverage (CFGR) | - - | 3.28 | 5.12 | 6.58 | 9.10 | 8.35 | 14.40 | 13.76 | 8.37 | 14.59 | 13.36 | 10.45 | 5.38 | - - | |
| EBITDA Coverage | 100 | 100 | 100 | 100 | 200 | 200 | 200 | 200 | 200 | 300 | 500 | 500 | - - | - - | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | -400 | -2,600 | -12,400 | - - | - - | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | - - | |
| Market Prospects | |||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | 0.33 | 0.12 | 0.02 | - - | - - | |
| Earnings Yield | -2.30 | -1.04 | -1.99 | 0.69 | 6.04 | 3.89 | 2.50 | 1.52 | 1.74 | 1.58 | 3.22 | 2.64 | -2.96 | - - | |
|
Price/Earnings (P/E)
|
-4,343.06 | -9,611.69 | -5,021.96 | 14,474.41 | 1,657.06 | 2,573.23 | 3,995.90 | 6,574.12 | 5,743.59 | 6,346.77 | 3,104.98 | 3,784.18 | -3,382.83 | - - | |
| Price/Earnings Growth (PEG) | - - | 176.86 | -55.51 | -107.22 | 1.42 | -51.76 | -3,556.35 | -241.05 | 131.28 | 253.87 | 17.85 | -290.74 | 23.06 | - - | |
|
Price/Book (P/B)
|
- - | -668.73 | -571.04 | -630.68 | 554.62 | 451.20 | 606.43 | 505.75 | 469.30 | 378.77 | 463.96 | 393.81 | 169.32 | - - | |
| Price/Tangible Book (P/TB) | - - | -668.73 | -571.04 | -630.68 | 554.62 | 451.20 | 606.43 | 505.75 | 469.30 | 378.77 | 463.96 | 393.81 | 169.32 | - - | |
| Price/Sales (P/S) | 153.10 | 138.38 | 130.27 | 128.30 | 192.06 | 155.25 | 211.41 | 223.10 | 313.41 | 354.84 | 454.33 | 391.12 | 183.54 | - - | |
|
Price/Cash Flow (P/CF)
|
2,352.31 | 2,668.09 | 1,703.16 | 1,315.12 | 2,046.73 | 1,847.49 | 1,464.94 | 1,467.55 | 3,185.99 | 2,493.73 | 4,194.96 | 4,301.38 | 3,006.96 | - - | |
| Price/Free CF (P/FCF) | 18,913.33 | -14,388.06 | 15,429.30 | 4,194.73 | 11,416.51 | 18,274.85 | 2,747.34 | 2,775.74 | 26,661.14 | -43,058.49 | -7,179.51 | -8,544.36 | -2,437.32 | - - | |
| Price/Operating CF (P/OCF) | 2,352.31 | 2,668.09 | 1,703.16 | 1,315.12 | 2,046.73 | 1,847.49 | 1,464.94 | 1,467.55 | 3,185.99 | 2,493.73 | 4,194.96 | 4,301.38 | 3,006.96 | - - |